New 2024 Clinical Practice Guideline Update! The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Survivorship have been updated to V.1.2024. The guidelines continue to recommend bioimpedance spectroscopy as a key technology for survivorship care. Discover the latest updates and comprehensive information in the NCCN Guidelines® by visiting NCCN.org. Learn More about bioimpedance spectroscopy technology from ImpediMed: https://ow.ly/Xh6050Syc13
About us
ImpediMed Limited is the world leader in the development and distribution of medical devices employing bioimpedance spectroscopy (BIS) technologies for use in the noninvasive clinical assessment and monitoring of fluid status. ImpediMed’s primary product range consists of a number of medical devices that aid surgeons, oncologists, therapists and radiation oncologists in the clinical assessment of patients for the potential onset of secondary lymphoedema. Pre-operative clinical assessment in cancer survivors, before the onset of symptoms, may prevent the condition from becoming a lifelong management issue and thus improve the quality of life of the cancer survivor. ImpediMed had the first medical device with an FDA clearance in the United States to aid health care professionals in the clinical assessment of secondary lymphoedema of the arm and leg in female and male cancer patients.
- Website
-
http://www.impedimed.com
External link for ImpediMed
- Industry
- Medical Equipment Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Carlsbad, CA
- Type
- Public Company
- Founded
- 1999
- Specialties
- Lymphedema, Fluid Status, Body Composition, Tissue Analysis, Breast Cancer, and Heart Failure
Locations
-
Primary
Get directions
5900 Pasteur Ct. Suite 125
Carlsbad, CA 92008, US
-
Get directions
Unit 1, 50 Parker Court
Pinkenba, Queensland 4008, AU
-
Get directions
Adrianoupoleos 24, 3os orofos
Kalamaria, Thessaloniki 55133, GR
Employees at ImpediMed
-
Steven Chen, MD, MBA
Surgical Oncologist | Chief Medical Officer | Biotechnology | Medical Device
-
Aaron Ogilvie
-
Richard Hines
Senior Manager of Regulatory Affairs
-
Amy Beth Gerzog
Always committed to empowering medical professionals to make smarter purchasing decisions without sacrificing patient care. Passion for animals, our…
Updates
-
We're excited to share the Lymphatic Education & Research Network (LEARN)'s latest report on the state of lymphedema care in the U.S. This comprehensive report sheds light on current knowledge and the importance of early detection, including the role of bioimpedance spectroscopy (BIS). This resource is vital for healthcare professionals, advocates, and policymakers to drive awareness and improve care standards. Access the report and the Communications Toolkit to join the advocacy efforts. #LymphedemaAwareness #BIS #EarlyDetection #LymphaticHealth
Read the full Report and download the Communications Toolkit here: https://lnkd.in/ex4bM5wU We are excited to announce the release of our groundbreaking report that provides the state of lymphedema knowledge and care in the United States. This first-of-its-kind report addresses the critical shortage of public health data regarding lymphedema's impact and equips you with discussion points to advocate. Download our Communications Toolkit to share the report with Advocates, Healthcare Professionals, and Policymakers. Maximizing the report's reach is crucial for advancing the future of lymphatic disease care and awareness.
-
-
🩺 The critical role of nurse navigators in lymphedema care is highlighted in this insightful article from Oncology Nursing News. Nurse navigators ensure timely and comprehensive care, addressing the unique challenges patients face with lymphedema. Their dedication helps in early detection, effective intervention, and continuous support, significantly improving patient outcomes. Read more about how these healthcare heroes are transforming lymphedema care: https://lnkd.in/gD8r3y3y #LymphedemaCare #NurseNavigators #HealthcareHeroes #PatientSupport
-
Survivorship is about thriving beyond a cancer diagnosis with strength and resilience. At ImpediMed, we support cancer survivors through every phase of their journey. Learn how our Lymphedema Prevention Program (LPP) is making a difference in the lives of breast cancer survivors. Discover more about preventing lymphedema and the support available to you: https://ow.ly/5KNU50SoIVP Let's honor the incredible stories of cancer survivors and raise awareness about their ongoing challenges. #CancerSurvivors #Survivorship #LymphedemaPrevention #HopeAndStrength
Lymphedema can’t ruin my survivorship, if I detect it early.
impedimed.com
-
Supporting survivors of cancer is at the heart of what we do. With SOZO®'s BIS technology now covered by Medicare and a growing number of private payors, we're improving patient access to early detection and management of lymphedema. This progress helps ensure cancer survivors receive the comprehensive care they need. Contact a specialist at ImpediMed to learn how SOZO® can benefit your practice and support patient well-being: https://ow.ly/kLR250Sl55m. #CancerSurvivorsMonth #LymphedemaPrevention #Reimbursement #HealthcareInnovation
-
-
Meet Elaine, Clinical Program Specialist at ImpediMed and a breast cancer survivor. Her journey highlights the incredible power of early detection and knowledge. Elaine says, "Knowledge is power." She's living proof that awareness about innovative technologies can be life-changing. It's about more than just technology; it's about empowering survivors to take control of their health. Our mission this Cancer Survivors Month is to ensure that survivors like Elaine can embrace life to the fullest, without limitations. Together, we're paving the way for a brighter, healthier future. #CancerSurvivorsMonth #KnowledgeIsPower #Survivorship"
-
-
🎥 Missed our webinar on ""Preventing Chronic Breast Cancer-Related Lymphedema: Practical Insights for Operationalizing a Lymphedema Surveillance Program""? No worries! You can now watch the recording at your convenience. Join our esteemed panel, including Dr. Steven Chen, Dr. Allison DiPasquale, and Dr. Manpreet Kohli, as they discuss early detection, clinical guideline updates, and best practices for implementing a Lymphedema Surveillance Program. Catch the full webinar here: https://ow.ly/qq8P50Sl4G5 Enhance your knowledge and stay updated on the latest in lymphedema prevention and care. #LymphedemaAwareness #BreastCancerCare #WebinarRecording #HealthcareEducation #ImpediMed
Preventing Chronic Breast Cancer-Related Lymphedema: Practical Insights for Operationalizing a Lymphedema Surveillance Program
impedimed.com
-
Announcing the 2024 Update to Clinical Practice Guidelines! The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Survivorship now include the latest V.1.2024 updates. Bioimpedance spectroscopy continues to be recognized as an essential technology in the care of survivors. Explore the most recent developments and detailed guidance in the NCCN Guidelines® by heading to NCCN Learn More about bioimpedance spectroscopy technology from ImpediMed: https://ow.ly/r7Hs50SfAxc
-
-
During National Cancer Survivors Month, we're honored to shine a light on Sheri Yolanda Prentiss MD MPH CPS/A CPE FACPE CSP® —a breast cancer and lymphedema survivor whose journey inspires us all. Dr. Sheri’s story embodies the theme of community support and resilience. As a fellow survivor, she intimately understands the challenges and triumphs of this path. Her experience fuels her passion for advocating on behalf of survivors like herself. Let’s stand together, celebrate our strength, and continue making a difference. Explore valuable community resources and support networks available for survivors: https://ow.ly/UqeL50SfASg #SurvivorSpotlight #CancerSurvivorsMonth #StrengthInSurvival #LymphedemaAwareness
-